Attentin 10 mg Tablette, Dexamfetamine sulfate 20 mg modified-release capsule, Placebo for Test 1 - 5 mg, Attentin 5 mg, Tablette, Placebo for test 2 - 10 mg, Placebo for test 1 - 10 mg, Placebo for test 2 - 20 mg, Dexamfetamine sulfate 15 mg modified-release capsule, Placebo for test 2 - 15 mg, Dexamfetamine sulfate 10 mg modified-release capsule
6520-9970-08
Phase 3 small_molecule active
Quick answer
Attentin 10 mg Tablette, Dexamfetamine sulfate 20 mg modified-release capsule, Placebo for Test 1 - 5 mg, Attentin 5 mg, Tablette, Placebo for test 2 - 10 mg, Placebo for test 1 - 10 mg, Placebo for test 2 - 20 mg, Dexamfetamine sulfate 15 mg modified-release capsule, Placebo for test 2 - 15 mg, Dexamfetamine sulfate 10 mg modified-release capsule for Patients with ADHD (according to ICD-10 / DSM-5) is a Phase 3 program (small_molecule) at Medice Arzneimittel Pütter GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Medice Arzneimittel Pütter GmbH & Co. KG
- Indication
- Patients with ADHD (according to ICD-10 / DSM-5)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active